Semax

Semax is a synthetic heptapeptide developed to mimic the active fragment of adrenocorticotropic hormone, widely studied for its potent neuroprotective and cognitive research properties. Scientific studies focus on its ability to stimulate Brain-Derived Neurotrophic Factor and improve cellular resilience under hypoxic conditions.

"The melanocortin analog Semax has demonstrated profound neuro-regulatory effects, significantly increasing neurotrophin expression in cellular culture models."

Academic publications and experimental models can be audited through the PubMed Repository or explored through genomic indexes at the NCBI Protein Registry for advanced neuroscience research. Preclinical research evaluates Semax for its potential to modulate gene expression related to the immune system and vascular endothelial growth factors.

Key Areas of Investigation:

• Neurotrophin Expression: Examining BDNF and NGF synthesis pathways in cortical tissue.
• Neuroprotection: Investigating cellular survivability during oxidative stress and hypoxia.
• Vascular Integrity: Studies on cerebral circulation and endothelial cell survival.

This material is supplied exclusively as a lyophilized solid for laboratory research and analytical evaluation, and is strictly not for human or therapeutic use.